XML 124 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value Measurements and Investments
12 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Investments
Note 6—Fair Value Measurements and Investments
The Company measures certain assets and liabilities at fair value. See Note 1—Summary of Significant Accounting Policies.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 
Fair Value Measurements at September 30
Using Inputs Considered as
 
Level 1
 
Level 2
 
2019
 
2018
 
2019
 
2018
 
(in millions)
Assets
 
 
 
 
 
 
 
Cash equivalents and restricted cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
6,494

 
$
6,252

 
 
 
 
U.S. government-sponsored debt securities
 
 
 
 
$
150

 
$
1,048

Investment securities:
 
 
 
 
 
 
 
Marketable equity securities
126

 
113

 
 
 
 
U.S. government-sponsored debt securities
 
 
 
 
5,592

 
5,008

U.S. Treasury securities
675

 
2,508

 
 
 
 
Other current and non-current assets:
 
 
 
 
 
 
 
Derivative instruments
 
 
 
 
437

 
78

Total
$
7,295

 
$
8,873

 
$
6,179

 
$
6,134

Liabilities
 
 
 
 
 
 
 
Accrued compensation and benefits:
 
 
 
 
 
 
 
Deferred compensation liability
$
113

 
$
96

 
 
 
 
Accrued and other liabilities:
 
 
 
 
 
 
 
Derivative instruments
 
 
 
 
$
52

 
$
22

Total
$
113

 
$
96

 
$
52

 
$
22


There were no transfers between Level 1 and Level 2 assets during fiscal 2019.
Level 1 assets and liabilities. Money market funds, marketable equity securities and U.S. Treasury securities are classified as Level 1 within the fair value hierarchy, as fair value is based on quoted prices in active markets. The Company’s deferred compensation liability is measured at fair value based on marketable equity securities held under the deferred compensation plan.
Level 2 assets and liabilities. The fair value of U.S. government-sponsored debt securities, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. The pricing data obtained from outside sources is reviewed internally for reasonableness, compared against benchmark quotes from independent pricing sources, then confirmed or revised accordingly. Derivative instruments are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data. There were no substantive changes to the valuation techniques and related inputs used to measure fair value during fiscal 2019.

U.S. government-sponsored debt securities and U.S. Treasury securities. The Company classifies U.S. government-sponsored debt securities and U.S. Treasury securities as available-for-sale. The amortized cost, unrealized gains and losses and fair value of debt securities are as follows:
 
September 30, 2019
 
September 30, 2018
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Gains
 
Losses
 
Gains
 
Losses
 
 
(in millions)
U.S. government-sponsored debt securities
$
5,590

 
$
4

 
$
(2
)
 
$
5,592

 
$
5,016

 
$

 
$
(8
)
 
$
5,008

U.S. Treasury securities
672

 
3

 

 
675

 
2,516

 

 
(8
)
 
2,508

Total
$
6,262

 
$
7

 
$
(2
)
 
$
6,267

 
$
7,532

 
$

 
$
(16
)
 
$
7,516

Less: current portion
 
 
 
 
 
 
$
(4,110
)
 
 
 
 
 
 
 
$
(3,434
)
Long-term debt securities
 
 
 
 
 
 
$
2,157

 
 
 
 
 
 
 
$
4,082


Debt securities are presented below in accordance with their stated maturities. A portion of these investments, $2.2 billion, are classified as non-current, as they have stated maturities of more than one year from the balance sheet date. However, these investments are generally available to meet short-term liquidity needs.
 
 
Fair Value
 
 
(in millions)
September 30, 2019:
 
 
Due within one year
 
$
4,110

Due after 1 year through 5 years
 
2,157

Total
 
$
6,267


Assets Measured at Fair Value on a Non-recurring Basis
Non-marketable equity securities. The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. These investments are classified as Level 3 due to the absence of quoted market prices, the inherent lack of liquidity and the fact that inputs used to measure fair value are unobservable and require management’s judgment.
The following table summarizes the total carrying value of our non-marketable equity securities held as of September 30, 2019 including unrealized gains and losses since the adoption of ASU 2016-01:
 
For the Year Ended
 
September 30, 2019
 
(in millions)
Carrying amount, beginning of period
$
137

Adjustments related to non-marketable equity securities:
 
Net additions (reductions)(1)
475

Upward adjustments
110

Downward adjustments(2)
(4
)
Carrying amount, end of period
$
718

(1) 
Net reductions include transfers to marketable equity securities upon investments becoming a public company.
(2) 
There were no significant impairment charges of non-marketable equity securities during fiscal 2019, 2018 and 2017.
Non-financial assets and liabilities. Long-lived assets such as goodwill, indefinite-lived intangible assets, finite-lived intangible assets and property, equipment and technology are considered non-financial assets. The Company does not have any non-financial liabilities measured at fair value on a non-recurring basis. Finite-lived intangible assets primarily consist of customer relationships, trade names and reseller relationships, all of which were obtained through acquisitions. See Note 8—Intangible Assets and Goodwill.
If the Company were required to perform a quantitative assessment for impairment testing of goodwill and indefinite-lived intangible assets, the fair values would generally be estimated using an income approach. As the assumptions employed to measure these assets on a non-recurring basis are based on management’s judgment using internal and external data, these fair value determinations are classified as Level 3 in the fair value hierarchy. The Company completed its annual impairment review of its indefinite-lived intangible assets and goodwill as of February 1, 2019, and concluded that there was no impairment. No recent events or changes in circumstances indicate that impairment existed at September 30, 2019. See Note 1—Summary of Significant Accounting Policies.
Investment Income
Investment income is recorded as non-operating income in the Company’s consolidated statements of operations and consisted of the following:
 
For the Years Ended
September 30,
 
2019
 
2018
 
2017
 
(in millions)
Interest and dividend income on cash and investments
$
247

 
$
173

 
$
92

Realized gains (losses), net on debt securities
1

 

 
(1
)
Equity securities:
 
 
 
 
 
Unrealized gains (losses), net
117

 
2

 
6

Realized gains (losses), net from donation

 
193

 

Realized gains (losses), net
18

 
102

 
8

Investment income
$
383

 
$
470

 
$
105


Other Fair Value Disclosures
Long-term debt. Debt instruments are measured at amortized cost on the Company’s consolidated balance sheets. The fair value of the debt instruments, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. The pricing data obtained from outside sources is reviewed internally for reasonableness, compared against benchmark quotes from independent pricing sources, then confirmed or revised accordingly. If measured at fair value in the financial statements, these instruments would be classified as Level 2 in the fair value hierarchy. The carrying value and estimated fair value of long-term debt was $16.7 billion and $18.4 billion as of September 30, 2019. The carrying value and estimated fair value of long-term debt were both $16.6 billion as of September 30, 2018.
Other Financial Instruments not Measured at Fair Value
The following financial instruments are not measured at fair value on the Company’s consolidated balance sheet at September 30, 2019, but require disclosure of their fair values: settlement receivable and payable, accounts receivable and customer collateral. The estimated fair value of such instruments at September 30, 2019 approximates their carrying value due to their generally short maturities. If measured at fair value in the financial statements, these financial instruments would be classified as Level 2 in the fair value hierarchy.